Monica Else
Impact in
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 41
- Chronic Lymphocytic Leukemia Research 42
-
- Lymphoma Diagnosis and Treatment 31
- Co-authors
- Daniel Catovsky (35 shared papers)Claire Dearden (21 shared papers)Estella Matutes (15 shared papers)Rachel Wade (9 shared papers)Sue Richards (8 shared papers)Zadie Davis (3 shared papers)Nnenna Osuji (5 shared papers)David Oscier (9 shared papers)
- Journals
- Blood (12 papers)British Journal of Haematology (10 papers)Haematologica (4 papers)Cancer (3 papers)Clinical Cancer Research (1 paper)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Monica Else
43 papers receiving 2.0k citations
Monica Else's Hit Papers
Peers
Comparison fields: 5 of 69
- Genetics 1.6k
- Pathology and Forensic Medicine 1.0k
- Immunology 621
- Hematology 316
- Oncology 342
Countries citing papers authored by Monica Else
This map shows the geographic impact of Monica Else's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Else with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Else more than expected).
Fields of papers citing papers by Monica Else
This network shows the impact of papers produced by Monica Else. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Else. The network helps show where Monica Else may publish in the future.
Co-authors
The 25 scholars most cited alongside Monica Else, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial Hit paper breakdown → | 2007 | 501 |
| 2 | 2009 | 182 | |
| 3 | 2012 | 152 | |
| 4 | 2007 | 105 | |
| 5 | 2007 | 101 | |
| 6 | 2010 | 84 | |
| 7 | 2005 | 82 | |
| 8 | 2008 | 82 | |
| 9 | 2011 | 59 | |
| 10 | 2011 | 57 | |
| 11 | 2014 | 55 | |
| 12 | 2015 | 54 | |
| 13 | 2011 | 51 | |
| 14 | 2012 | 49 | |
| 15 | 2012 | 47 | |
| 16 | 2011 | 44 | |
| 17 | 2008 | 41 | |
| 18 | 2007 | 38 | |
| 19 | 2011 | 37 | |
| 20 | 2008 | 34 |
About Monica Else
Monica Else is a scholar working on Genetics, Pathology and Forensic Medicine, Immunology, Oncology and Molecular Biology, having authored 44 papers that have together received 2.1k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (42 papers), Lymphoma Diagnosis and Treatment (31 papers), Immunodeficiency and Autoimmune Disorders (13 papers), Viral-associated cancers and disorders (7 papers), Glycosylation and Glycoproteins Research (3 papers), Acute Lymphoblastic Leukemia research (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Genetics (1.6k citations), Pathology and Forensic Medicine (1.0k citations), Immunology (621 citations), Hematology (316 citations) and Oncology (342 citations). Monica Else has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Daniel Catovsky, Claire Dearden, Estella Matutes, Rachel Wade, Sue Richards, Zadie Davis, Nnenna Osuji, David Oscier, David González de Castro and Peter Hillmen. Their work appears in journals such as Blood, British Journal of Haematology, Haematologica, Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.